2EBMT Statistical Unit ▲ Sign in to save

• ▲ Luuk A. Gras

  Leiden University · European Society for Blood and Marrow Transplantation Medicine
  5.08k

  citations

  32

  h-index

  51

  Aachen papers
• ▲ Dirk‐Jan Eikema

  European Society for Blood and Marrow Transplantation Medicine
  1.02k

  citations

  19

  h-index

  57

  Aachen papers
• ▲ Diderik-Jan Eikema

  Leiden University Medical Center · European Society for Blood and Marrow Transplantation Medicine
  703

  citations

  14

  h-index

  18

  Aachen papers

3 results

• Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms?

  2024 Blood article Medicine Acute Myeloid Leukemia Research Open access

  26

  citations
• Early Hepatotoxicity in Patients with Myelofibrosis after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)

  2022 Blood article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment

  3

  citations
• Transplant Outcomes for Acute Myeloid Leukemia or Myelodysplastic Syndromes Secondary to Acquired Aplastic Anemia or Paroxysmal Nocturnal Hemoglobinuria: A Report from the EBMT Severe Aplastic Anemia Working Party

  2023 Blood conference-abstract Medicine Hematopoietic Stem Cell Transplantation

  2

  citations
• Worldwide Network for Blood and Marrow Transplantation (WBMT) Global Study on Baseline Characteristics and Clinical Outcomes in NEWLY Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous STEM Cell Transplantation, a Study Off 61,725 Patients from 629 Centers

  2022 Blood article Medicine Multiple Myeloma Research and Treatments

  1

  citations
• Post-Transplant Cyclophosphamide (PTCY) Compared to ATG in Patients with Myelodysplastic Neoplasms Allografted with an Unrelated Donor: A Registry Study of the Chronic Malignancies Working Party of the EBMT

  2023 Blood conference-abstract Medicine Hematopoietic Stem Cell Transplantation

  1

  citations
• Alternative Donor Transplantation for Severe Aplastic Anemia: A Comparative Study of the Saawp EBMT

  2023 Blood conference-abstract Medicine Hematopoietic Stem Cell Transplantation Open access

  1

  citations
• Autologous Hematopoietic Cell Transplantation for T-Cell Prolymphocytic Leukemia - a Retrospective Study on Behalf of the Chronic Malignancies Working Party of the EBMT

  2022 Blood article Medicine Hematopoietic Stem Cell Transplantation Open access

  0

  citations
• Gvhd Prophylaxis Incorporating Methotrexate in Allo-HCT for Chronic Myeloid Malignancies and sAML: A Retrospective Analysis from the Cmwp of the EBMT

  2022 Blood article Medicine Hematopoietic Stem Cell Transplantation

  0

  citations
• Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) in Patients with Calr-Mutated Myelofibrosis

  2022 Blood article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment

  0

  citations
• Autologous Peripheral Blood Stem Cell Mobilisation Techniques, Stem Cell Yields and Practice Variation-By-Country in Patients with Myeloma Undergoing First Autologous Stem Cell Transplants in EBMT Centres between 2012 and 2021

  2022 Blood article Medicine Multiple Myeloma Research and Treatments

  0

  citations
• International Differences in Baseline Characteristics and Practice Patterns in Patients with NEWLY Diagnosed Multiple Myeloma Undergoing Upfront Autologous STEM Cell Transplantation

  2022 Blood article Medicine Multiple Myeloma Research and Treatments

  0

  citations
• Allogeneic Hematopoietic Cell Transplantation in Patients with Therapy-Related Myeloid Neoplasm Following Treatment for Lymphoma: A Study of the Chronic Malignancies Working Party of the EBMT

  2022 Blood article Medicine Hematopoietic Stem Cell Transplantation

  0

  citations
• Long Term Outcomes and Renal Response Following Autologous Stem Cell Transplantation for Light Chain Deposition Disease:a Retrospective Study on Behalf of the Cmwp of the EBMT

  2023 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes

  0

  citations
• Impact of Post-Transplant Cyclophosphamide (PTCY)-Based Prophylaxis in Matched Sibling Donor Allo-HCT for Patients with Myelodysplastic Syndrome: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT

  2023 Blood conference-abstract Medicine Hematopoietic Stem Cell Transplantation

  0

  citations
• Conditioning Intensity in Patients Aged > 50 Years Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrom: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT

  2023 Blood conference-abstract Medicine Hematopoietic Stem Cell Transplantation Open access

  0

  citations
• Impact of Age on Outcome in Newly Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Cell Transplantation from the Worldwide Network for Blood and Marrow Transplantation Global Study

  2023 Blood conference-abstract Medicine Multiple Myeloma Research and Treatments

  0

  citations
• Cryopreserved Versus Non-Cryopreserved Peripheral Blood Haematopoietic Stem Cells for Autologous Stem Cell Transplantation in Multiple Myeloma: A Comparative Analysis from the Chronic Malignancies Working Party of EBMT and WBMT

  2023 Blood conference-abstract Medicine Hematopoietic Stem Cell Transplantation Open access

  0

  citations
• Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome in Young Adults. a Retrospective Study on Behalf of the Chronic Malignancies Working Party of the EBMT

  2024 Blood conference-abstract Medicine Hematopoietic Stem Cell Transplantation

  0

  citations

18 results